← Selected work

In-Office Kits

Lab collection moved into the clinic — kits, activation flows, and a sticker. Labs series, part 3.

Role
Product Designer — Labs (kits design lead)
Timeline
August 2024 – January 2026
Team
1 Product designer, kits design lead (me) · 1 Staff product designer (Labs design lead) · 1 Content designer · 1 Product manager · Labs engineering and operations
Scope
Wholesale kit ordering · Activation flows · Kit packaging (physical) · In-office draws research program · Practitioner web

My role

  • Led discovery for in-office kits, running the sessions that framed the practitioner ordering and stocking workflow.
  • Designed the wholesale browsing, ordering, and reordering experience, including the 20-unit cart cap and its error states.
  • Designed 3 activation flows — direct link, patient profile, and catalog — so kits work however a practitioner arrives.
  • Designed the kit sticker, the physical brand touchpoint on every box that ships to a clinic.
  • Owned the in-office draws research program: practitioner interview guide, jobs-to-be-done synthesis, comparative lab analysis, and the discovery workshop.
  • Ran Loom walkthroughs to align the Labs team asynchronously before handoff.
Physical lab kit box with a Fullscript activation sticker and barcode

TL;DR

In short

Problem

Practitioners who draw blood in their own clinic had to source collection supplies from third parties, track inventory by hand, and coordinate specimen logistics outside the platform their labs already ran on.

Approach

Ran discovery first, then designed wholesale ordering around how clinics actually stock — familiar commerce patterns, hard operational limits turned into helpful guardrails, and a physical artifact treated as part of the product.

Outcome

The pilot’s top kit logged 524 orders in its first months; kits reached general availability in January 2026 and the research program seeded the in-office phlebotomy work that continues today.


Context and problem

The situation we walked into

Business context

Labs launched with mobile phlebotomy and lab visits — both of which route the patient away from the clinic. A large segment of integrative practitioners already draw blood in-office and needed supplies, not services. Kits extended Labs into that segment: wholesale collection supplies, ordered and restocked inside the platform, with Fullscript’s logistics behind them.

User context

Clinic operators think in inventory, not orders: what’s on the shelf, what runs out mid-day, what to reorder before it does. They already know how to draw blood — the product’s job was a trustworthy supplier with an ordering flow that respects how clinics stock, not clinical education.

Constraints and complexity

Supply-chain realities imposed a 20-unit cart cap that design had to make feel like guidance rather than a wall. Practitioners could arrive from 3 different contexts, each needing its own activation path. And part of the deliverable was physical: the kit box and its sticker are the product’s most visible surface inside a clinic.


Goals and success metrics

What success looked like

A practitioner can stock their office from Fullscript without contacting support — browse, order, restock — and the kit that arrives feels like part of the platform, not a third-party shipment.

Success criteria

  • Kits ship as a pilot in 2025 with wholesale ordering live end to end.
  • All 3 activation paths reach production.
  • Practitioners reorder without support intervention.
  • The program graduates from pilot to general availability.

Approach

How we got there

  1. 01

    Ran discovery before design

    Booked discovery sessions with the Labs team the week the kits work opened, mapping how practitioners source, stock, and run out of supplies. The sessions reframed the product from “a store for kits” to “a restocking workflow” — clinics buy on rhythm, not impulse, and the design followed that rhythm.

  2. 02

    Designed wholesale ordering on familiar patterns

    Built browsing, cart, and reorder flows on commerce patterns practitioners already know — catalog, product detail, cart — rather than inventing a medical-supply paradigm. Reordering from order history became the primary loop, because a clinic’s second order is the one that predicts retention.

  3. 03

    Turned the 20-unit cap into a guardrail

    Supply constraints capped carts at 20 units per kit. Instead of a generic error at checkout, the limit surfaces early, in context, with specific copy about what to do — turning the highest-frustration moment in bulk ordering into an expectation set upfront.

  4. 04

    Treated the physical kit as a design surface

    Designed the sticker that ships on every kit box — the one Fullscript touchpoint sitting on a clinic shelf between orders. A small artifact, argued for deliberately: the box is the brand’s only physical presence in the practitioner’s space.

  5. 05

    Extended into the draws research program

    Owned the research that carried kits’ momentum into in-office draws: a practitioner interview guide, jobs-to-be-done synthesis, a comparative analysis of lab providers’ in-office programs, and the discovery workshop that shaped the roadmap. The program continued past my involvement — the design work seeded it.


Key decisions

Forks in the road

Commerce patterns vs a clinical supply portal

Some practitioners expected something resembling a medical-supply portal — dense tables, catalog numbers, quote requests. Familiar e-commerce patterns (browse, card, cart) were the other path: less “clinical,” but zero learning curve for users who already shop online.

Decision
Built the catalog on commerce patterns practitioners already know, styled to the Labs design language.
Tradeoff
Traded supply-portal signaling for immediate usability — the right call for a product whose success metric is unassisted reorders.

Surface the cart cap early vs enforce it at checkout

The 20-unit cap was non-negotiable operationally. Enforcing it at checkout is the standard implementation, but it converts a supply-chain constraint into a last-second rejection — the worst moment to surprise someone stocking a clinic for the month.

Decision
Exposed the limit in context while ordering, with specific copy about the cap and what to do about larger needs.
Tradeoff
More states and copy to design and build, in exchange for a constraint that reads as guidance instead of failure.

3 activation paths vs one onboarding flow

Practitioners arrive at kits from meaningfully different contexts: a direct link from the team, a patient’s profile, or the catalog. One unified onboarding is cheaper to build, but every entry point would carry the wrong assumptions for 2 of the 3 audiences.

Decision
Designed a distinct activation path per entry point — direct link, patient profile, and catalog.
Tradeoff
3× the activation surface to design and maintain, in exchange for each practitioner landing in a flow that matches their intent.

Research the draws program before designing it

In-office draws could have started from a brief — the demand signal was already loud. But the workflow crosses practitioner, patient, and courier, and a brief written before research would have encoded guesses about the messiest parts.

Decision
Built the research program first: interviews, jobs-to-be-done, comparative analysis, then a discovery workshop to shape the roadmap.
Tradeoff
Design started weeks later than it could have — and inherited a scope grounded in observed workflow instead of assumption.

Solution

What we shipped

Wholesale lab-kit catalog with product cards and a stock-total counter
The wholesale catalog uses commerce patterns practitioners already know, so first orders need no training.
Inventory-limit modal explaining how many more kits a practitioner can stock
The 20-unit cap surfaces during ordering with specific copy — a guardrail met early, not a rejection met at checkout.
Kit activation screen where a practitioner selects the test for a stocked kit
Activating a stocked kit: pick the test, then hand it to the patient — one of the three paths a practitioner can enter from.

Outcomes and impact

What it moved

Top kit, pilot

524 orders

The Comprehensive Metabolic Panel led the pilot’s first months, with CBC (439) and Estradiol (396) behind it.

General availability

January 2026

Kits graduated from a year of piloting to GA.

Program seeded

Ongoing

The kits work and draws research seeded the in-office phlebotomy program that continues today.

Business impact

Kits opened Labs to the segment the original phlebotomy model skipped: clinics that already draw blood and needed supplies inside the platform. By early 2026 the program had graduated to general availability, and in-office collection had become one of the most-requested capabilities across the labs product — demand the draws research program was built to meet.

User impact

Practitioners stock their clinic from the same platform that runs their labs — browse, order, restock — without support tickets or third-party suppliers. The activation paths land each practitioner in a flow matching how they arrived, and the kit on the shelf carries the platform’s design language into the clinic itself.


Learnings and reflections

What I’d take with me

  • Unglamorous surfaces decide retention

    Reorder flows, quantity caps, and activation paths never make a highlight reel, but the clinic that restocks without friction is the one that stays. The second order — not the first — turned out to be the design target that mattered.

  • A sticker is an interface

    The kit box sits on a clinic shelf for weeks — the platform’s only physical presence in the practitioner’s space. Treating the sticker as a design surface, argued for like any feature, bought brand trust no screen could.

  • Research momentum outlives the researcher

    The draws program kept moving after my part ended because the research artifacts — interview guide, jobs-to-be-done, workshop outputs — were built to be picked up by others. Research that only lives in the researcher’s head isn’t a program; it’s a bottleneck.